MedTrace Logo

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

NCT05108298 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2026-05-07

No results posted yet for this study

Summary

The purpose of this study is to evaluate feasibility and acceptability of completing PROs among AYAs randomized to Choice PRO vs Fixed PRO.

Conditions

  • Breast Cancer, NOS
  • CNS Primary Tumor, NOS
  • Cervical Cancer, NOS
  • Colorectal Cancer, NOS
  • Leukemia, NOS
  • Lymphoma, NOS
  • Miscellaneous Neoplasm, NOS
  • Non-Rhabdomyosarcoma Soft Tissue Sarcoma, NOS
  • Testicular Nonseminomatous Germ Cell Tumor, NOS
  • Thyroid Cancer, NOS
  • Melanoma
  • Bone Cancer, NOS

Interventions

OTHER

Questionnaires

Patients will complete questionnaires online through EASEE-PRO. There will be a set of fixed questionnaires at each timepoint for both arms. The patients will be asked to rank the 15 types of PROs according to their importance. The participants randomized to the choice arm will be asked to choose 5 of the 15 PROs to complete. The participants randomized to the fixed arm will be given a fixed 5 of the 15 PROs at each time point.

Sponsors & Collaborators

  • Eastern Cooperative Oncology Group

    lead NETWORK

Principal Investigators

  • John M Salsman, PhD · ECOG-ACRIN Cancer Research Group

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-10
Primary Completion
2027-05-01
Completion
2027-05-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05108298 on ClinicalTrials.gov